君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01877 君实生物

未开盘 12-05 16:09:08

23.560

-0.400

-1.67%

最高24.240	最低23.340	成交量295.92万
今开24.160	昨收23.960	日振幅3.76%
总市值241.96亿	流通市值61.26亿	总股本10.27亿
成交额6,987万	换手率1.14%	流通股本2.60亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01877","market":"HK","secType":"STK","nameCN":"君实生物","latestPrice":23.56,"timestamp":1764922148002,"preClose":23.96,"halted":0,"volume":2959200,"delay":0,"floatShares":260000000,"shares":1027000000,"eps":-1.4313915378926472,"marketStatus":"未开盘","change":-0.4,"latestTime":"12-05 16:09:08","open":24.16,"high":24.24,"low":23.34,"amount":69866643,"amplitude":0.037563,"askPrice":23.56,"askSize":4200,"bidPrice":23.54,"bidSize":7800,"shortable":3,"etf":0,"ttmEps":-1.05588028184189,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":0,"adr":0,"listingDate":1545580800000,"exchange":"SEHK","adjPreClose":23.96,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":1.7037054097030846,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688180","market":"SH","secType":"STK","nameCN":"君实生物","latestPrice":36,"timestamp":1764918000000,"preClose":35.75,"halted":0,"volume":4356200,"delay":0,"premium":"-40.56"}},"requestUrl":"/m/hq/s/01877/wiki","defaultTab":"wiki","newsList":[{"id":"2589891877","title":"君实生物：自愿披露关于偌考奇拜单抗注射液新药上市申请获得受理的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2589891877","media":"证券日报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589891877?lang=zh_cn&edition=full","pubTime":"2025-12-07 20:37","pubTimestamp":1765111021,"startTime":"0","endTime":"0","summary":"证券日报网讯12月5日晚间，君实生物发布公告称，近日，公司收到国家药品监督管理局核准签发的《受理通知书》，公司产品偌考奇拜单抗注射液（重组人源化抗IL-17A单克隆抗体注射液，产品代号：JS005）用于治疗适合系统治疗或光疗的中度至重度斑块状银屑病的成人患者的新药上市申请获得受理。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512073584622992.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","BK1583","BK0239","01877","688180","BK1161"],"gpt_icon":0},{"id":"2589784876","title":"君实生物：拓益®新增适应症和君适达®纳入国家医保目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2589784876","media":"证券之星","labels":["productRelease","policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589784876?lang=zh_cn&edition=full","pubTime":"2025-12-07 15:40","pubTimestamp":1765093209,"startTime":"0","endTime":"0","summary":"君实生物公告称，公司产品特瑞普利单抗注射液2项新增适应症和昂戈瑞西单抗注射液成功纳入《国家基本医疗保险、生育保险和工伤保险药品目录》乙类范围。新版国家医保目录将于2026年1月1日起正式实施。拓益已在中国内陆获批的12项适应症全部纳入国家医保目录，是目录中唯一用于肾癌、三阴性乳腺癌和黑色素瘤治疗的抗PD-1单抗药物；君适达为首次纳入，是新版目录中唯一用于他汀不耐受人群的国产PCSK9靶点药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120700002591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1161","BK1515","BK1583","01877","688180"],"gpt_icon":0},{"id":"2589928878","title":"君实生物抗IL-17A单抗银屑病新药上市申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2589928878","media":"中金财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589928878?lang=zh_cn&edition=full","pubTime":"2025-12-07 10:38","pubTimestamp":1765075080,"startTime":"0","endTime":"0","summary":"中访网数据 上海君实生物医药科技股份有限公司今日宣布，其自主研发的创新药偌考奇拜单抗注射液用于治疗中重度斑块状银屑病的新药上市申请，已获得国家药品监督管理局受理。该药物是一款重组人源化抗IL-17A单克隆抗体，通过阻断炎症信号通路发挥作用。若获批上市，偌考奇拜单抗将为该患者群体提供新的治疗选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251207/31849162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","BK1583","BK1515","BK1161","01877","688180"],"gpt_icon":0},{"id":"2589189805","title":"君实生物(688180.SH)：偌考奇拜单抗注射液新药上市申请获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2589189805","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589189805?lang=zh_cn&edition=full","pubTime":"2025-12-05 17:27","pubTimestamp":1764926866,"startTime":"0","endTime":"0","summary":"智通财经APP讯，君实生物 发布公告，近日，公司收到国家药品监督管理局核准签发的《受理通知书》，公司产品偌考奇拜单抗注射液用于治疗适合系统治疗或光疗的中度至重度斑块状银屑病的成人患者的新药上市申请获得受理。截至公告披露日，除本次新药上市申请外，偌考奇拜单抗用于治疗活动性强直性脊柱炎的Ⅱ期临床研究的所有参与者已完成治疗，进入安全随访期。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378190.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688180","BK1515","BK1583","01877","BK0239","BK1161"],"gpt_icon":0},{"id":"2589852136","title":"上海君实生物医药科技股份有限公司发布2025年11月证券变动月报","url":"https://stock-news.laohu8.com/highlight/detail?id=2589852136","media":"中访网数据","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589852136?lang=zh_cn&edition=full","pubTime":"2025-12-05 07:55","pubTimestamp":1764892514,"startTime":"0","endTime":"0","summary":"中访网数据  上海君实生物医药科技股份有限公司于2025年12月4日向香港交易及结算所有限公司提交了截至2025年11月30日的证券变动月报表。报告显示，公司法定股本及已发行股份在本月内保持稳定，未发生变动。截至11月底，公司法定/注册股本总额为人民币1,026,689,871元。根据公司股份期权计划，截至11月底，根据H股股票期权激励计划授出的期权数目为13,210,000份，本月无变动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205080055a7249b9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205080055a7249b9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01877","BK1161","BK1515","BK1583","BK1574","09939"],"gpt_icon":0},{"id":"2588880821","title":"君实生物（688180）披露证券变动月报，12月4日股价上涨1.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588880821","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588880821?lang=zh_cn&edition=full","pubTime":"2025-12-04 22:07","pubTimestamp":1764857238,"startTime":"0","endTime":"0","summary":"截至2025年12月4日收盘，君实生物报收于35.75元，较前一交易日上涨1.1%，最新总市值为367.04亿元。公司近日发布公告，披露截至2025年11月30日的证券变动月报。公告显示，君实生物H股和A股的法定/注册股本、已发行股份及库存股份数目均无变动。H股股票期权激励计划项下结存期权数目为13,210,000股，A股股票期权激励计划项下结存期权数目为24,700,000股，较上月减少450,000股，因部分期权注销所致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400039389.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688180","BK1583","BK0239","01877","161027","BK1515","BK1161"],"gpt_icon":0},{"id":"2588895883","title":"君实生物：上海檀英减持1200万股完毕 占总股本的1.1688%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588895883","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588895883?lang=zh_cn&edition=full","pubTime":"2025-12-04 18:08","pubTimestamp":1764842924,"startTime":"0","endTime":"0","summary":"12月4日，君实生物（688180/01877）发布公告，股东上海檀英通过大宗交易方式减持1200万股，占公司总股本的1.1688%。减持计划时间区间已届满。2025年前三季度，君实生物实现收入18.06亿元，归母净利润-5.96亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512043582789075.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","688180","BK1161","01877","BK0239","BK1583"],"gpt_icon":0},{"id":"1161513739","title":"上海君实生物（01877）2025年11月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1161513739","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161513739?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:35","pubTimestamp":1764837354,"startTime":"0","endTime":"0","summary":"上海君实生物医药科技股份有限公司于2025年12月4日发布2025年11月股份变动月报表。本次月报披露，公司在报告期内股本结构保持稳定，未发生新增发行、回购或注销股份的情况。报告期内，公司注册股本总额为人民币1,026,689,871元，涵盖260,295,700股H股与766,394,171股A股，两类股份数量均与上月保持一致。针对激励计划，H股股票期权数量维持在13,210,000份，当月无新增行使或取消。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877"],"gpt_icon":0},{"id":"2589852132","title":"每日卖空追踪 | 君实生物 12月04日卖空量成交8.18万股，卖空比例为5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589852132","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589852132?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837026,"startTime":"0","endTime":"0","summary":"君实生物北京时间12月04日，涨1.1%，卖空量成交8.18万股，较上一交易日增加17.19%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163358952a7b85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163358952a7b85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1583","01877","BK1161"],"gpt_icon":0},{"id":"2588483710","title":"君实生物：绿地金融投资控股集团有限公司及其一致行动人持股比例已降至4.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588483710","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588483710?lang=zh_cn&edition=full","pubTime":"2025-12-03 19:12","pubTimestamp":1764760349,"startTime":"0","endTime":"0","summary":"南财智讯12月3日电，君实生物公告，因H股股份出借，绿地金融投资控股集团有限公司及其一致行动人上海加财投资管理有限公司、GreenlandFinancialOverseasInvestmentGroupCo.,Ltd的持股比例合计由5.0051%下降至4.7129%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512033581707486.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","159940","BK1583","01877","BK1515","688180","BK0239"],"gpt_icon":0},{"id":"2588011059","title":"每日卖空追踪 | 君实生物 12月03日卖空量成交3.56万股，卖空比例为2.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588011059","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588011059?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:30","pubTimestamp":1764750623,"startTime":"0","endTime":"0","summary":"君实生物北京时间12月03日，跌1.33%，卖空量成交3.56万股，较上一交易日减少82.98%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203163341a4c9ef4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203163341a4c9ef4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","01877","BK1161","BK1515"],"gpt_icon":0},{"id":"2588011721","title":"君实生物12月03日遭主力抛售250.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588011721","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588011721?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:15","pubTimestamp":1764749748,"startTime":"0","endTime":"0","summary":"12月03日, 君实生物股价跌1.33%，报收23.70元，成交金额3532.1万元，换手率0.57%，振幅2.58%，量比0.67。君实生物今日主力资金净流出250.1万元，上一交易日主力净流出239.5万元。该股近5个交易日下跌5.24%，主力资金累计净流入1396.9万元；近20日主力资金累计净流入1893.3万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203162008a7210550&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203162008a7210550&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","BK1515","01877"],"gpt_icon":0},{"id":"2588608692","title":"港股生物医药板块持续走低，泰格医药、君实生物跌超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588608692","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588608692?lang=zh_cn&edition=full","pubTime":"2025-12-02 11:49","pubTimestamp":1764647365,"startTime":"0","endTime":"0","summary":"港股生物医药板块持续走低，泰格医药、君实生物跌超3%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512023580206556.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512023580206556.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1146622755.USD","BK1515","03347","01877","BK0028","BK0174","BK1161","161726","BK0216","688180","BK0239","300347","399441","LU1820825898.SGD","BK1141","BK1576","BK1583","BK0077"],"gpt_icon":0},{"id":"2588603053","title":"君实生物12月1日获融资买入1297.06万元，融资余额13.67亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588603053","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588603053?lang=zh_cn&edition=full","pubTime":"2025-12-02 09:17","pubTimestamp":1764638274,"startTime":"0","endTime":"0","summary":"两融数据显示，当日君实生物获融资买入额1297.06万元，融资偿还1504.49万元，融资净买入-207.43万元。截至12月1日，君实生物融资融券余额合计13.78亿元。融资方面，君实生物当日融资买入1297.06万元。融券方面，君实生物12月1日融券偿还400.00股，融券卖出700.00股，按当日收盘价计算，卖出金额2.56万元；融券余量29.45万股，融券余额1075.39万元，超过近一年80%分位水平，处于高位。截至9月30日，君实生物股东户数3.59万，较上期增加15.17%；人均流通股21361股，较上期减少12.96%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202092151978ab284&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202092151978ab284&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","BK1515","01877"],"gpt_icon":0},{"id":"2588477912","title":"每日卖空追踪 | 君实生物 12月01日卖空量成交28.08万股，卖空比例为14.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588477912","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588477912?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:30","pubTimestamp":1764577825,"startTime":"0","endTime":"0","summary":"君实生物北京时间12月01日，跌2.13%，卖空量成交28.08万股，较上一交易日增加74.41%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116331695244859&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116331695244859&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01877","BK1583","BK1515","BK1161"],"gpt_icon":0},{"id":"2586890237","title":"每日卖空追踪 | 君实生物 11月28日卖空量成交7.02万股，卖空比例为4.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586890237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586890237?lang=zh_cn&edition=full","pubTime":"2025-11-28 16:30","pubTimestamp":1764318623,"startTime":"0","endTime":"0","summary":"君实生物北京时间11月28日，跌0.47%，卖空量成交7.02万股，较上一交易日增加2.63%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128164237a4bffae7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128164237a4bffae7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","BK1515","01877"],"gpt_icon":0},{"id":"2586242593","title":"君实生物(01877)拟使用暂时闲置募集资金进行现金管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2586242593","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586242593?lang=zh_cn&edition=full","pubTime":"2025-11-27 19:27","pubTimestamp":1764242829,"startTime":"0","endTime":"0","summary":"智通财经APP讯，君实生物(01877)发布公告，公司将按照相关规定严格控制风险，拟使用暂时闲置募集资金投资安全性高、流动性好的保本型投资产品(包括但不限于通知存款、定期存款、协定存款、组合存款、存单及结构性存款等)，且该等产品不得用于质押，不用于以证券投资为目的的投资行为。公司计划使用最高不超过人民币24亿元(包含本数)的暂时闲置募集资金进行现金管理。根据募集资金使用情况以及公司经营情况，将暂时闲置募集资金分笔按不同期限投资上述产品，最长期限不超过12个月。在前述额度和期限内，资金可以循环滚动使用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374657.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01877","BK1161","BK0239","BK1515","BK1583","688180"],"gpt_icon":0},{"id":"2586236106","title":"君实生物注射用JS107启动III期临床 适应症为CLDN18.2阳性的晚期胃或胃食管结合部腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2586236106","media":"新浪财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586236106?lang=zh_cn&edition=full","pubTime":"2025-11-26 12:03","pubTimestamp":1764129780,"startTime":"0","endTime":"0","summary":"药物临床试验登记与信息公示平台数据显示，上海君实生物医药科技股份有限公司的一项评估JS107对比研究者选择治疗作为CLDN18.2阳性的晚期胃或胃食管结合部腺癌的二线或以上治疗的有效性和安全性的多中心、随机、对照、开放的III期临床研究已启动。注射用JS107为生物制品，适应症为CLDN18.2阳性的晚期胃或胃食管结合部腺癌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126130900951af84c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126130900951af84c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","01877","BK1161","BK1515"],"gpt_icon":0},{"id":"2586284330","title":"港股异动 | 君实生物(01877)再涨超5% 特瑞普利单抗皮下注射III期临床达主要终点 后续拟申报上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2586284330","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586284330?lang=zh_cn&edition=full","pubTime":"2025-11-26 11:09","pubTimestamp":1764126584,"startTime":"0","endTime":"0","summary":"消息面上，君实生物宣布，由公司自主研发的特瑞普利单抗注射液对比特瑞普利单抗注射液联合化疗一线治疗复发或转移性非鳞状非小细胞肺癌的多中心、开放、随机对照Ⅲ期临床研究达到主要研究终点。君实生物计划将于近期向监管部门递交该产品的上市许可申请。公开资料显示，JS001sc是公司在已上市产品特瑞普利单抗注射液的基础上开发的皮下注射制剂，为首款进入III期临床研究阶段的国产抗 PD-1 单抗皮下制剂，有望给患者带来用药的便捷性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373733.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK0239","688180","BK1515","III","BK4134","BK1161","01877"],"gpt_icon":0},{"id":"2586289514","title":"生物医药股悉数走强 荣昌生物(09995)涨6.65% 机构指医药行业近期震荡调整后估值已回落至相对低位","url":"https://stock-news.laohu8.com/highlight/detail?id=2586289514","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586289514?lang=zh_cn&edition=full","pubTime":"2025-11-26 10:08","pubTimestamp":1764122938,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药股悉数走强，截至发稿，荣昌生物 涨6.65%，复宏汉霖涨4.85%，君实生物涨4.43%，康诺亚-B涨4.01%，康方生物涨3.62%，泰格医药涨3.33%，诺诚健华涨3.14%。总体上，2026年预计政策端仍将驱动医药行业腾笼换鸟、创新升级。该机构看好2026年医药行业投资机会，近期震荡调整后估值已回落至相对低位，有望在2026年重启升势，投资思路上寻找医药硬科技和细分赛道α，推荐关注创新药、创新器械、医疗AI方向，关注医药消费复苏及独立第三方ICL。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970350","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348766576.USD","LU0417516902.SGD","09926","BK1141","IE00B5MMRT66.SGD","01877","LU0348767384.USD","LU0417516571.SGD","BK1161","LU1064130708.USD","688331","BK1583","LU0634319403.HKD","BK1515","161726","BK1587","02696","LU2476274308.USD","LU0540923850.HKD","03347","IE00B543WZ88.USD","LU0348825331.USD","LU0348783233.USD","LU1064131003.USD","02162","LU1969619763.USD","09969","BK1576","LU0561508036.HKD","LU1794554557.SGD","LU1961090484.USD","IE00BPRC5H50.USD","LU2399975544.HKD","LU2476274720.SGD","LU2488822045.USD","LU1720050803.USD","LU2328871848.SGD","BK0239","LU2778985437.USD","09995","LU0417516738.SGD","HK0000165453.HKD","BK1574","LU0348784397.USD","LU0348735423.USD","LU0348827113.USD","LU2148510915.USD","399441"],"gpt_icon":0}],"profile":{"websiteUrl":"http://junshipharma.com","stockEarnings":[{"period":"1week","weight":-0.0695},{"period":"1month","weight":-0.0868},{"period":"3month","weight":-0.3171},{"period":"6month","weight":0.1035},{"period":"1year","weight":0.793},{"period":"ytd","weight":1.0345}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.0058},{"period":"3month","weight":0.0262},{"period":"6month","weight":0.0964},{"period":"1year","weight":0.3336},{"period":"ytd","weight":0.3004}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海君实生物医药科技股份有限公司是一家主要从事创新驱动生物制药业务的中国公司。该公司主营业务为创新药物的发现、临床研究和开发。该公司的主要产品包括特立普珠单抗注射液、依替维单抗、阿达木单抗注射液等用于治疗恶性肿瘤、自身免疫系统疾病、慢性代谢疾病、神经系统疾病和感染性疾病的药物。该公司还从事重组人源化抗PCSK9单克隆抗体注射液等药物的临床研发。该公司主要为国内外市场提供产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.142857,"avgChangeRate":-0.112475},{"month":2,"riseRate":0.857143,"avgChangeRate":0.07747},{"month":3,"riseRate":0.714286,"avgChangeRate":0.049127},{"month":4,"riseRate":0.857143,"avgChangeRate":0.101581},{"month":5,"riseRate":0.428571,"avgChangeRate":0.004505},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.018268},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.014588},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.040587},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.026161},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.004518},{"month":11,"riseRate":0.571429,"avgChangeRate":0.043753},{"month":12,"riseRate":0.571429,"avgChangeRate":0.097844}],"exchange":"SEHK","name":"君实生物","nameEN":"JUNSHI BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供君实生物(01877)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"君实生物,01877,君实生物股票,君实生物股票老虎,君实生物股票老虎国际,君实生物行情,君实生物股票行情,君实生物股价,君实生物股市,君实生物股票价格,君实生物股票交易,君实生物股票购买,君实生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供君实生物(01877)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}